Entering text into the input field will update the search result below

Recro Pharma GAAP EPS of $0.04 beats by $0.11, revenue of $22.3M beats by $0.89M

Mar. 01, 2022 4:14 PM ETSocietal CDMO, Inc. (SCTL)By: Urvi Shah, SA News Editor
  • Recro Pharma press release (NASDAQ:REPH): Q4 GAAP EPS of $0.04 beats by $0.11.
  • Revenue of $22.3M (+125.0% Y/Y) beats by $0.89M.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About SCTL

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Societal CDMO, Inc.
Medicine Man Technologies, Inc.
Rain Oncology Inc.
Sol-Gel Technologies Ltd.
Goodness Growth Holdings, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.